Filing Details

Accession Number:
0002029477-25-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-08-08 16:30:37
Reporting Period:
2025-08-07
Filing Date:
2025-08-08
Accepted Time:
2025-08-08 16:30:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1861560 Nuvalent Inc. NUVL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2029477 E. Henry Pelish C/O Nuvalent, Inc.
One Broadway, 14Th Floor
Cambridge MA 02142
Chief Scientific Officer No No No No
Transaction Summary
Sold: 5,500 shares Avg. Price: $74.85 Total Value: $411,675.00
Number of Shares After Transactions: 60,956 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2025-08-07 731 $18.93 61,687 No 4 M Direct
Class A Common Stock Acquisiton 2025-08-07 877 $27.85 62,564 No 4 M Direct
Class A Common Stock Acquisiton 2025-08-07 3,892 $29.33 66,456 No 4 M Direct
Class A Common Stock Disposition 2025-08-07 5,500 $74.85 60,956 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (Right to Buy) Disposition 2025-08-07 731 $0.00 731 $18.93
Class A Common Stock Stock Option (Right to Buy) Disposition 2025-08-07 877 $0.00 877 $27.85
Class A Common Stock Stock Option (Right to Buy) Disposition 2025-08-07 3,892 $0.00 3,892 $29.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,368 2032-01-04 No 4 M Direct
26,573 2033-01-06 No 4 M Direct
16,967 2033-03-01 No 4 M Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2024.
  2. The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
  3. The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
  4. The shares underlying this option have vested or shall vest over the four years following March 1, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.